Alpha Diagnostic International

Alpha Diagnostic International (ADI) located in San Antonio, Texas, USA, is a major provider of custom peptides synthesis and antibodies. Established in 1993, ADI specializes in the development, manufacture, and distribution of a variety of ELISA reagents and kits for animal and human research.

ADI is one of the first biotech companies to research, develop, test, and improve many classical vaccines for diphtheria, tetanus, pertussis, hepatitis, rabies, measles, mumps, rubella, polio, meningitis and tuberculosis. ADI has developed tests for many recombinant or subunit vaccines for malaria, cholera, anthrax, ebola, encephalitis, influenza, congo, and papilloma (HPV) viruses. ADI has also developed rapid and sensitive ELISA methods to identify and measure the activity components of various vaccines when adsorbed on adjuvants such as Alum.

We have many new adjuvants (peptides, proteins, DNA or ODNs, RNA, and chemicals) to improve vaccines. ADI also offers custom ELISA and vaccine sample testing. Most recently, ADI has developed 1-hour field tests to detect horse, pig, rat, cat, and dog meat adulteration of beef and other meat products for human and animal consumption.

Showing 0 of 0 results